| One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey, Mexico JM Llaca-Díaz, S Mendoza-Olazarán, A Camacho-Ortiz, S Flores, ... Chemotherapy 58 (6), 475-481, 2013 | 136 | 2013 |
| Helicobacter pylori drug resistance: therapy changes and challenges S Flores-Treviño, S Mendoza-Olazarán, P Bocanegra-Ibarias, ... Expert review of gastroenterology & hepatology 12 (8), 819-827, 2018 | 128 | 2018 |
| Stenotrophomonas maltophilia biofilm: its role in infectious diseases S Flores-Treviño, P Bocanegra-Ibarias, A Camacho-Ortiz, R Morfín-Otero, ... Expert review of anti-infective therapy 17 (11), 877-893, 2019 | 104 | 2019 |
| A snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period E Garza-González, R Morfín-Otero, S Mendoza-Olazarán, ... plos One 14 (3), e0209865, 2019 | 98 | 2019 |
| Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity S Flores-Treviño, JL Gutierrez-Ferman, R Morfín-Otero, ... Journal of medical microbiology 63 (11), 1524-1530, 2014 | 79 | 2014 |
| Microbiological and molecular characterization of Staphylococcus hominis isolates from blood S Mendoza-Olazarán, R Morfin-Otero, E Rodríguez-Noriega, J Llaca-Díaz, ... PLoS One 8 (4), e61161, 2013 | 65 | 2013 |
| First report of Clostridium difficile NAP1/027 in a Mexican hospital A Camacho-Ortiz, D López-Barrera, R Hernández-García, ... PLoS One 10 (4), e0122627, 2015 | 57 | 2015 |
| The evolution of antimicrobial resistance in Mexico during the last decade: results from the INVIFAR Group E Garza-González, R Franco-Cendejas, R Morfín-Otero, G Echaniz-Aviles, ... Microbial Drug Resistance 26 (11), 1372-1382, 2020 | 49 | 2020 |
| Screening of biomarkers of drug resistance or virulence in ESCAPE pathogens by MALDI-TOF mass spectrometry S Flores-Treviño, E Garza-González, S Mendoza-Olazarán, ... Scientific reports 9 (1), 18945, 2019 | 47 | 2019 |
| Risk factors and molecular mechanisms associated with trimethoprim–sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico SA Herrera-Heredia, C Pezina-Cantú, E Garza-González, ... Journal of medical microbiology 66 (8), 1102-1109, 2017 | 45 | 2017 |
| Drug resistance and molecular epidemiology of Mycobacterium tuberculosis in Mexico: a systematic review S Flores-Treviño, S Mendoza-Olazarán, E Garza-González salud pública de méxico 56 (1), 63-77, 2014 | 36 | 2014 |
| Genetic Diversity of Mycobacterium tuberculosis from Guadalajara, Mexico and Identification of a Rare Multidrug Resistant Beijing Genotype S Flores-Treviño, R Morfín-Otero, E Rodríguez-Noriega, E González-Díaz, ... PLoS One 10 (2), e0118095, 2015 | 33 | 2015 |
| Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the infivar network E Garza-González, P Bocanegra-Ibarias, M Bobadilla-del-Valle, ... PLoS One 16 (3), e0248614, 2021 | 32 | 2021 |
| Circulation of Highly Drug-Resistant Clostridium difficile Ribotypes 027 and 001 in Two Tertiary-Care Hospitals in Mexico A Martínez-Meléndez, L Tijerina-Rodríguez, R Morfin-Otero, ... Microbial Drug Resistance 24 (4), 386-392, 2018 | 30 | 2018 |
| The successful containment of a hospital outbreak caused by NDM-1-producing Klebsiella pneumoniae ST307 using active surveillance P Bocanegra-Ibarias, E Garza-González, M Padilla-Orozco, ... PLoS One 14 (2), e0209609, 2019 | 29 | 2019 |
| High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile … L Tijerina-Rodríguez, L Villarreal-Treviño, SD Baines, R Morfín-Otero, ... PLoS One 14 (7), e0220671, 2019 | 27 | 2019 |
| Intestinal microbiome changes in fecal microbiota transplant (FMT) vs. FMT enriched with Lactobacillus in the treatment of recurrent Clostridioides difficile infection E Garza-González, S Mendoza-Olazarán, R Morfin-Otero, ... Canadian Journal of Gastroenterology and Hepatology 2019 (1), 4549298, 2019 | 27 | 2019 |
| Clinical predictors of drug-resistant tuberculosis in Mexico S Flores-Treviño, E Rodríguez-Noriega, E Garza-González, ... PloS one 14 (8), e0220946, 2019 | 25 | 2019 |
| Sexually transmitted pathogens, coinfections and risk factors in patients attending obstetrics and gynecology clinics in Jalisco, Mexico N Casillas-Vega, R Morfín-Otero, S García, J Llaca-Díaz, ... salud pública de méxico 58 (4), 437-445, 2016 | 23 | 2016 |
| Aztreonam plus ceftazidime-avibactam as treatment of NDM-1-producing Klebsiella pneumoniae bacteraemia in a neutropenic patient: Last resort therapy? P Bocanegra-Ibarias, A Camacho-Ortiz, E Garza-González, ... Journal of global antimicrobial resistance 23, 417-419, 2020 | 21 | 2020 |
